Female Reproductive System Neoplasm Clinical Trials in Rochester, Minnesota
4 recruitingRochester, Minnesota
Showing 1–4 of 4 trials
Recruiting
Phase 2
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Solid NeoplasmMalignant Female Reproductive System NeoplasmRecurrent Malignant Solid Neoplasm+1 more
National Cancer Institute (NCI)70 enrolled185 locationsNCT06126276
Recruiting
Phase 2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Malignant Female Reproductive System Neoplasm+12 more
National Cancer Institute (NCI)2,900 enrolled479 locationsNCT05564377
Recruiting
Phase 4
Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery
Malignant Female Reproductive System Neoplasm
Mayo Clinic140 enrolled1 locationNCT06525740
Recruiting
Not Applicable
Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions
Ovarian CarcinomaOvarian NeoplasmsFemale Reproductive System Adnexal Neoplasm+3 more
Mayo Clinic40 enrolled1 locationNCT07280312